Skip to content
★ Sign in to follow
MB

Marc Better

Executive
Kite Pharma, Inc.
Total declarations
51
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (40 ops.)
€4.9M

Latest filing published 03 Feb 2016 for Kite Pharma, Inc., €216k.

Insider track record

Disclosed buys
0
Disclosed sells
40
Signal history

Marc Better: trading record in brief

Marc Better is a declared insider of Kite Pharma, Inc., with filings sourced from SEC (Form 4). We count 51 filings; the first trade dates from 1 May 2015 and the latest from 1 February 2016.

The open-market record consists of 40 sales worth €4.9M, with no purchase. Outside the open market, there are 1 share grant and 10 option exercises. 2016 to date brings no purchases and 7 sales.

The latest filing, published on 3 February 2016, reports an open-market sale of €216k in Kite Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Marc Better

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations51 total
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    233,962 USD31SEC
    4,938 shares@ US$47.3823.9% of flowCommon StockSEC:0001209191-16-095525:2
  • ◇
    VP, Product SciencesExecutivesKite Pharma, Inc.
    0SEC
    9,000 sharesCommon StockSEC:0001209191-16-095525:0
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    68,343 USD30SEC
    1,410 shares@ US$48.477.0% of flowCommon StockSEC:0001209191-16-095525:3
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    7,528 USD29SEC
    153 shares@ US$49.200.8% of flowCommon StockSEC:0001209191-16-095525:4
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    116,204 USD30SEC
    2,499 shares@ US$46.5011.9% of flowCommon StockSEC:0001209191-16-095525:1
  • ◇
    VP, Product SciencesExecutivesKite Pharma, Inc.
    0SEC
    9,000 sharesCommon StockSEC:0001209191-16-089427:0
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    414,294 USD15SEC
    6,719 shares@ US$61.6642.2% of flowCommon StockSEC:0001209191-16-089427:2
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    6,868 USD11SEC
    110 shares@ US$62.440.7% of flowCommon StockSEC:0001209191-16-089427:3
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    132,626 USD12SEC
    2,171 shares@ US$61.0913.5% of flowCommon StockSEC:0001209191-16-089427:1
  • ◆
    VP, Product SciencesExecutivesKite Pharma, Inc.
    0SEC
    5,800 shares0Common StockSEC:0001209191-15-086487:0
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    67,450 USD0SEC
    905 shares@ US$74.53Common StockSEC:0001209191-15-083374:1
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    209,231 USD0SEC
    2,772 shares@ US$75.48Common StockSEC:0001209191-15-083374:2
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    280,552 USD0SEC
    3,664 shares@ US$76.57Common StockSEC:0001209191-15-083374:3
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    94,163 USD0SEC
    1,215 shares@ US$77.50Common StockSEC:0001209191-15-083374:4
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    19,947 USD0SEC
    254 shares@ US$78.53Common StockSEC:0001209191-15-083374:5
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    8,059 USD0SEC
    100 shares@ US$80.59Common StockSEC:0001209191-15-083374:6
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    7,418 USD0SEC
    90 shares@ US$82.42Common StockSEC:0001209191-15-083374:7
  • ◇
    VP, Product SciencesExecutivesKite Pharma, Inc.
    3,420 USD0SEC
    9,000 shares@ US$0.38Common StockSEC:0001209191-15-083374:0
  • ◇
    VP, Product SciencesExecutivesKite Pharma, Inc.
    3,420 USD0SEC
    9,000 shares@ US$0.38Common StockSEC:0001209191-15-078541:0
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    40,250 USD0SEC
    590 shares@ US$68.22Common StockSEC:0001209191-15-078541:1
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    36,650 USD0SEC
    525 shares@ US$69.81Common StockSEC:0001209191-15-078541:2
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    203,822 USD0SEC
    2,876 shares@ US$70.87Common StockSEC:0001209191-15-078541:3
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    350,964 USD0SEC
    4,899 shares@ US$71.64Common StockSEC:0001209191-15-078541:4
  • ▼
    VP, Product SciencesExecutivesKite Pharma, Inc.
    7,965 USD0SEC
    110 shares@ US$72.41Common StockSEC:0001209191-15-078541:5
  • ◇
    VP, Product SciencesExecutivesKite Pharma, Inc.
    3,420 USD0SEC
    9,000 shares@ US$0.38Common StockSEC:0001209191-15-073538:0

25 of 51 declarations